https://news.medxy.ai/ja/beyond-communication-dementia-care/Medxy AIja2026-04-03T12:44:51-07:00コミュニケーションを超えて：認知症の終末期医療利用と言語障壁の関連 https://news.medxy.ai/vi/language-barriers-alzheimer-hospital-use/Medxy AIvi2026-04-03T12:41:36-07:00Ngoài giao tiếp: Rào cản ngôn ngữ liên quan đến việc sử dụng bệnh viện cao hơn vào cuối đời trong bệnh Alzheimer https://news.medxy.ai/language-barriers-hospital-utilization/Medxy AIen2026-04-03T12:37:52-07:00Beyond Communication: Language Barriers Linked to Higher Hospital Utilization at End-of-Life in Dementia https://news.medxy.ai/zh/severe-babesiosis-red-cell-exchange/Medxy AIzh2026-04-03T12:28:51-07:00严重巴贝斯病的红细胞交换输血：改善生存率和临床结局的证据 https://news.medxy.ai/ja/red-cell-exchange-transfusion-babesiosis/Medxy AIja2026-04-03T12:27:28-07:00重症巴贝斯虫病的红细胞交换输血：提高生存率和临床结果的证据 https://news.medxy.ai/vi/blood-transfusion-babesiosis/Medxy AIvi2026-04-03T12:25:07-07:00Truyền máu thay thế hồng cầu cho bệnh Babesiosis nặng: Bằng chứng về sự cải thiện tỷ lệ sống sót và kết quả lâm sàng https://news.medxy.ai/red-blood-cell-exchange-babesiosis/Medxy AIen2026-04-03T12:22:38-07:00Red Blood Cell Exchange Transfusion for Severe Babesiosis: Evidence for Improved Survival and Clinical Outcomes https://news.medxy.ai/zh/fluoxetine-covid-fatigue-results/Medxy AIzh2026-04-03T12:11:18-07:00氟西汀在治疗长期COVID疲劳方面显示前景：来自适应性随机试验的结果 https://news.medxy.ai/ja/fulbocare-hope-for-chronic-fatigue/Medxy AIja2026-04-03T12:10:14-07:00フルボキサミン、持続性コロナ疲労症候群の治療に有望：適応無作為化試験の結果 https://news.medxy.ai/vi/fluvoxamine-covid-fatigue/Medxy AIvi2026-04-03T12:08:21-07:00Fluvoxamine Hiển Thị Hứa Hẹn trong Điều Trị Mệt Mỏi Dài Hạn do COVID-19: Kết Quả từ Thử Nghiệm Ngẫu Nhiên Tự Động Điều Chỉnh https://news.medxy.ai/flussamine-long-covid-fatigue/Medxy AIen2026-04-03T12:04:42-07:00Fluvoxamine Shows Promise for Treating Long COVID Fatigue: Results from Adaptive Randomized Trial https://news.medxy.ai/zh/limited-success-gvhd-treatment/Medxy AIzh2026-04-03T11:46:30-07:00有限成功：三线治疗在糖皮质激素难治性伴胃肠道受累的急性移植物抗宿主病中的疗效 https://news.medxy.ai/ja/limited-success-gvhd-treatment/Medxy AIja2026-04-03T11:44:39-07:00限られた成功：ステロイド抵抗性の急性GVHD（消化器系関与）に対する第三選択療法が微弱な反応を示す https://news.medxy.ai/vi/limited-success-third-line-therapy-agvhd/Medxy AIvi2026-04-03T11:41:20-07:00Thành công hạn chế: Liệu pháp tuyến thứ ba cho aGvHD có liên quan đến đường tiêu hóa kháng corticosteroid đạt phản ứng khiêm tốn https://news.medxy.ai/limited-success-third-line-therapy-agvhd/Medxy AIen2026-04-03T11:38:15-07:00Limited Success: Third-Line Therapy Yields Modest Responses in Steroid-Refractory aGvHD with GI Involvement https://news.medxy.ai/zh/oncolytic-virus-multiple-myeloma/Medxy AIzh2026-04-03T11:18:43-07:00溶瘤牛疱疹病毒1型：多发性骨髓瘤免疫微环境重塑的新策略 https://news.medxy.ai/ja/reconstructing-microenvironment-multiple-myeloma/Medxy AIja2026-04-03T11:16:34-07:00多発性骨髄腫の免疫微小環境再構築における新型戦略：ボーバインヘルペスウイルス1型のオンコライティック効果 https://news.medxy.ai/vi/bovine-herpesvirus-oncology/Medxy AIvi2026-04-03T11:14:49-07:00Bovine Herpesvirus Type 1 Onco-lý: Chiến lược mới để tái cấu trúc vi môi trường miễn dịch trong bệnh đa u tủy https://news.medxy.ai/oncolytic-bhv1-myloema-remodeling/Medxy AIen2026-04-03T11:11:37-07:00Oncolytic Bovine Herpesvirus Type 1: A Novel Strategy for Immune Microenvironment Remodeling in Multiple Myeloma https://news.medxy.ai/zh/ribosome-collision-zak-toxicity/Medxy AIzh2026-04-03T10:56:46-07:00核糖体碰撞与ZAK依赖的核糖毒性应激反应：慢性髓系白血病的一种新型治疗脆弱性 https://news.medxy.ai/ja/ribosome-collision-cml-therapy/Medxy AIja2026-04-03T10:55:12-07:00リボソームの衝突とZAK依存性リボソーム毒性ストレス応答：慢性骨髄性白血病の新たな治療脆弱性 https://news.medxy.ai/vi/ribosome-stress-response-zak/Medxy AIvi2026-04-03T10:53:08-07:00Va chạm ribosome và đáp ứng căng thẳng ribotoxic phụ thuộc ZAK: Một điểm yếu điều trị mới trong bệnh bạch cầu mạn tính dòng tủy https://news.medxy.ai/ribosome-collisions-cml/Medxy AIen2026-04-03T10:49:47-07:00Ribosome Collisions and the ZAK-Dependent Ribotoxic Stress Response: A Novel Therapeutic Vulnerability in Chronic Myeloid Leukemia https://news.medxy.ai/zh/enterococcus-mhc-ii-mechanism/Medxy AIzh2026-04-03T09:05:53-07:00肠球菌粪肠亚种驱动肠道上皮表达MHC-II：一种将肠道微生物群失调与致命移植物抗宿主病联系起来的新机制 https://news.medxy.ai/ja/faecalis-mhc-ii-gvhd/Medxy AIja2026-04-03T09:04:35-07:00腸球菌faecalisが腸上皮におけるMHC-IIの発現を駆動する：腸内細菌叢の乱れと致死性GVHDの関連を解明する新規メカニズム https://news.medxy.ai/vi/enterococcus-faecalis-mhc-ii-gvhd/Medxy AIvi2026-04-03T09:02:49-07:00Enterococcus faecalis Kích Thích Biểu Hiện MHC-II trong niêm mạc ruột: Cơ Chế Mới Liên Kết Sự mất cân bằng vi sinh vật đường ruột với Bệnh Graft-versus-Host gây chết người https://news.medxy.ai/enterococcus-faecalis-mhc-ii-gvhd/Medxy AIen2026-04-03T08:58:27-07:00Enterococcus faecalis Drives MHC-II Expression in Intestinal Epithelium: A Novel Mechanism Linking Gut Microbiome Dysbiosis to Lethal Graft-versus-Host Disease https://news.medxy.ai/zh/mechanical-ventilation-ards-mortality-trend/Medxy AIzh2026-04-02T20:34:53-07:00机械通气 ARDS 患者的死亡率趋势：20 年的悖论揭示 https://news.medxy.ai/ja/ards-mortality-trends/Medxy AIja2026-04-02T20:33:23-07:00機械換気下のARDS患者の死亡率の動向：20年間の逆説が明らかに https://news.medxy.ai/vi/ards-mortality-trends/Medxy AIvi2026-04-02T20:31:42-07:00Xu hướng tử vong ở bệnh nhân ARDS được thông khí máy: 20 năm nghịch lý được tiết lộ https://news.medxy.ai/mortality-trends-ards/Medxy AIen2026-04-02T20:26:59-07:00Mortality Trends in Mechanically Ventilated ARDS: 20 Years of Paradox Revealed https://news.medxy.ai/zh/deep-capillary-defects-diabetic-retinopathy/Medxy AIzh2026-04-02T18:48:18-07:00糖尿病视网膜病变中深部毛细血管丛缺陷成为全视网膜区域缺血的通用生物标志物 https://news.medxy.ai/ja/diabetic-retinopathy-biomarker/Medxy AIja2026-04-02T18:45:54-07:00糖尿病性视网膜病变中深部毛细血管丛缺陷成为全视网膜区域视网膜缺血的普遍生物标志 https://news.medxy.ai/vi/deep-plexus-defects-diabetic-retinopathy/Medxy AIvi2026-04-02T18:44:03-07:00Các khuyết tật plexus mao mạch sâu xuất hiện như một dấu hiệu sinh học phổ quát cho thiếu máu võng mạc trên tất cả các vùng võng mạc trong bệnh võng mạc đái tháo đường https://news.medxy.ai/deep-capillary-defects-biomarker/Medxy AIen2026-04-02T18:39:36-07:00Deep Capillary Plexus Defects Emerge as a Universal Biomarker for Retinal Ischemia Across All Retinal Regions in Diabetic Retinopathy https://news.medxy.ai/zh/semaglutide-and-non-arteritic-anterior-ischemic-optic-neuropathy/Medxy AIzh2026-04-02T18:32:14-07:00司美格鲁肽与非动脉炎性前部缺血性视神经病变：目标试验模拟和全球药物警戒的证据综合 https://news.medxy.ai/ja/semaglutide-vision-issues/Medxy AIja2026-04-02T18:30:43-07:00セマグルチドと非動脈炎性前部虚血性視神経症：対象試験の模倣と世界の薬物警戒からの証拠の統合 https://news.medxy.ai/vi/semaglutide-and-cns-disease/Medxy AIvi2026-04-02T18:28:28-07:00Semaglutide và Bệnh Thần Kinh Quang Không Động Mạch Trước Phi Động Mạch: Tổng Hợp Bằng Chứng từ Các Thử Nghiệm Mô Phỏng và Giám Sát Dược Lực Toàn Cầu https://news.medxy.ai/semaglutide-optic-neuropathy/Medxy AIen2026-04-02T18:22:54-07:00Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: Synthesizing Evidence from Target Trial Emulations and Global Pharmacovigilance https://news.medxy.ai/zh/fluocinolone-diabetic-edema-study/Medxy AIzh2026-04-02T18:15:02-07:00氟轻松玻璃体内植入物在糖尿病黄斑水肿患者中实现视觉结果相当，注射次数减少53%：第4期NEW DAY研究 https://news.medxy.ai/ja/diabetic-macular-edema-fac-results/Medxy AIja2026-04-02T18:13:40-07:00糖尿病黄斑浮腫患者中，FAc 眼内植入物的視力結果與阿柏西普相当，但注射次数减少53%：第4期 NEW DAY 研究 https://news.medxy.ai/vi/intravitreal-fac-study-results/Medxy AIvi2026-04-02T18:11:56-07:00Cấy ghép Intravitreal FAc đạt kết quả thị lực tương đương với ít 53% số lần tiêm trong bệnh phù hoàng điểm do đái tháo đường: Nghiên cứu giai đoạn 4 NEW DAY https://news.medxy.ai/fac-intravitreal-implant-diabetic-edema/Medxy AIen2026-04-02T18:08:13-07:00FAc Intravitreal Implant Achieves Comparable Visual Outcomes with 53% Fewer Injections in Diabetic Macular Edema: Phase 4 NEW DAY Study https://news.medxy.ai/zh/beyond-binaries-cochlear-implant-assessment/Medxy AIzh2026-04-02T17:51:17-07:00超越二元：一种四阶段风险分层工具变革人工耳蜗植入候选评估 https://news.medxy.ai/ja/beyond-binaries/Medxy AIja2026-04-02T17:49:58-07:00バイナリを超えて：4段階リスク層別化ツールが人工内耳適合性評価を変革 https://news.medxy.ai/vi/overcoming-binary-risks/Medxy AIvi2026-04-02T17:46:52-07:00Vượt qua nhị phân: Công cụ phân loại rủi ro 4 giai đoạn biến đổi đánh giá khả năng cấy ghép ốc tai https://news.medxy.ai/beyond-binary-risk-tool/Medxy AIen2026-04-02T17:41:43-07:00Beyond Binary: A 4-Stage Risk Stratification Tool Transforms Cochlear Implant Candidacy Assessment https://news.medxy.ai/zh/opioid-use-reduction/Medxy AIzh2026-04-02T17:30:50-07:00塞来昔布将喉部手术后的阿片类药物使用量减少近一半——且不会增加疼痛 https://news.medxy.ai/zh/higher-risk-pancreas-surgery/Medxy AIzh2026-04-02T17:30:15-07:00研究发现：从微创手术转为开放胰腺切除术的风险更高 https://news.medxy.ai/ja/celecoxib-opioid-use-reduction/Medxy AIja2026-04-02T17:29:40-07:00セレコキシブが喉頭手術後のオピオイド使用量をほぼ半減—痛みは増加せず https://news.medxy.ai/ja/minimally-invasive-surgery-complication-risk/Medxy AIja2026-04-02T17:29:09-07:00最小侵襲手術から開腹膵臓切除術への変換は、研究によると合併症リスクが高い https://news.medxy.ai/vi/celecoxib-reduces-opioid-use/Medxy AIvi2026-04-02T17:27:56-07:00Celecoxib Giảm Gần Một Nửa Sử Dụng Opioid Sau Phẫu Thuật Họng—Mà Không Tăng Đau https://news.medxy.ai/zh/enhancing-weak-patients/Medxy AIzh2026-04-02T17:27:49-07:00增强虚弱患者：老年胃癌手术中的多模式预康复与临床韧性 https://news.medxy.ai/ja/weakness-enhancement-surgery/Medxy AIja2026-04-02T17:26:58-07:00虚弱の強化：老年胃癌手術における多モードプレハビリテーションと臨床的レジリエンス https://news.medxy.ai/vi/minimally-invasive-to-open-pancreatic-surgery/Medxy AIvi2026-04-02T17:26:48-07:00Việc chuyển đổi từ phẫu thuật ít xâm lấn sang phẫu thuật mở trong cắt tụy bên trái có nguy cơ biến chứng cao hơn, nghiên cứu cho thấy https://news.medxy.ai/celecoxib-opioid-reduction/Medxy AIen2026-04-02T17:25:16-07:00Celecoxib Cuts Opioid Use Nearly in Half After Throat Surgery—Without Increasing Pain https://news.medxy.ai/vi/strengthening-vulnerable-elders/Medxy AIvi2026-04-02T17:24:40-07:00Củng cố người yếu đuối: Tiền tập đa phương thức và khả năng chịu đựng lâm sàng trong phẫu thuật ung thư dạ dày ở người già https://news.medxy.ai/minimally-invasive-to-open-pancreatectomy-complications/Medxy AIen2026-04-02T17:23:58-07:00Conversion from Minimally Invasive to Open Pancreatectomy Carries Higher Complication Risk, Study Finds https://news.medxy.ai/strengthening-frail-geriatric-surgery/Medxy AIen2026-04-02T17:22:05-07:00Strengthening the Frail: Multimodal Prehabilitation and Clinical Resilience in Geriatric Gastric Cancer Surgery https://news.medxy.ai/minimum-caseload-study/Medxy AIen2026-04-02T17:11:04-07:00Volume Matters: New Study Defines Minimum Annual Caseload for Safer Fenestrated and Branched Aortic Repair https://news.medxy.ai/zh/research-finds-vascular-biomarker-predicts-early-delivery/Medxy AIzh2026-04-02T17:05:21-07:00足月时抗血管生成谱型预示低风险妊娠更快分娩 https://news.medxy.ai/ja/anti-angiogenic-profile-predicts-early-delivery/Medxy AIja2026-04-02T17:04:06-07:00満期妊娠における抗血管新生プロフィールが低リスク妊娠の早期分娩を示唆 https://news.medxy.ai/vi/anti-angiogenesis-late-pregnancy/Medxy AIvi2026-04-02T17:02:20-07:00Hồ sơ Chống Angiogenesis vào cuối thai kỳ báo hiệu thời gian chuyển dạ nhanh hơn trong các thai kỳ có nguy cơ thấp, nghiên cứu cho thấy https://news.medxy.ai/anti-angiogenic-profile-labour-onset/Medxy AIen2026-04-02T16:59:31-07:00Anti-Angiogenic Profile at Term Signals Faster Labour Onset in Low-Risk Pregnancies, Study Finds https://news.medxy.ai/zh/fecal-biosample-collection/Medxy AIzh2026-04-02T16:02:42-07:00妇科肿瘤学中粪便生物样本收集：新研究证明可行性并确定提供者参与为主要驱动因素 https://news.medxy.ai/ja/gynecologic-oncology-biomarker-collection/Medxy AIja2026-04-02T16:01:33-07:00婦人科腫瘍学における便生体試料採取: 新研究の実現可能性と医療提供者の関与が主要な推進力となることが示される https://news.medxy.ai/vi/biomarker-sampling-gynecological-cancer/Medxy AIvi2026-04-02T15:59:12-07:00Thu thập mẫu sinh học phân trong ung thư phụ khoa: Nghiên cứu mới chứng minh khả thi và xác định sự tham gia của bác sĩ là yếu tố quyết định https://news.medxy.ai/stool-biospecimen-collection/Medxy AIen2026-04-02T15:54:33-07:00Stool Biospecimen Collection in Gynecologic Oncology: New Study Demonstrates Feasibility and Identifies Provider Engagement as Key Driver https://news.medxy.ai/zh/timely-delivery-large-fetus/Medxy AIzh2026-04-02T14:47:23-07:00适时分娩大胎龄胎儿：早期引产的案例 https://news.medxy.ai/ja/large-fetus-delivery-timing/Medxy AIja2026-04-02T14:45:53-07:00大型胎児の分娩タイミング：早期誘発のケース https://news.medxy.ai/vi/early-labor-induction/Medxy AIvi2026-04-02T14:43:59-07:00Thời gian sinh nở cho thai nhi lớn hơn tuổi thai: Trường hợp cho việc gây chuyển dạ sớm https://news.medxy.ai/timing-delivery-early-induction/Medxy AIen2026-04-02T14:40:59-07:00Timing Delivery for Large-for-Gestational-Age Fetuses: The Case for Earlier Induction https://news.medxy.ai/zh/increased-anemia-burden-pregnancy/Medxy AIzh2026-04-02T14:40:27-07:00妊娠期贫血负担的增加：流行病学趋势、临床影响及管理策略的发展 https://news.medxy.ai/ja/anemia-in-pregnancy-2/Medxy AIja2026-04-02T14:38:45-07:00妊娠中の貧血の増加：疫学的動向、臨床的影響、および進化する管理戦略 https://news.medxy.ai/vi/anemia-in-pregnancy-trends/Medxy AIvi2026-04-02T14:37:06-07:00Gánh nặng ngày càng tăng của thiếu máu trong thai kỳ: Xu hướng dịch tễ học, tác động lâm sàng và các chiến lược quản lý mới https://news.medxy.ai/anemia-in-pregnancy/Medxy AIen2026-04-02T14:34:50-07:00The Rising Burden of Anemia in Pregnancy: Epidemiological Trends, Clinical Impact, and Evolving Management Strategies https://news.medxy.ai/zh/virtual-biopsy-validation-2/Medxy AIzh2026-04-02T14:05:32-07:00验证虚拟活检：非侵入性替代终点在MASH中的疾病进展和治疗效果 https://news.medxy.ai/ja/virtual-biopsy-validation-3/Medxy AIja2026-04-02T14:03:32-07:00仮想生検の検証: 疾患進行と治療効果の非侵襲的代替エンドポイント https://news.medxy.ai/vi/virtual-biopsy-validation/Medxy AIvi2026-04-02T14:01:09-07:00Xác minh Sinh thiết Ảo: Các Điểm Kết thúc Thay thế Không xâm lấn để Dự đoán Tiến triển Bệnh và Hiệu quả Điều trị trong MASH https://news.medxy.ai/validating-virtual-biopsy/Medxy AIen2026-04-02T13:58:33-07:00Validating the Virtual Biopsy: Noninvasive Surrogate Endpoints for Disease Progression and Treatment Efficacy in MASH https://news.medxy.ai/zh/new-model-predicts-hcc-survival/Medxy AIzh2026-04-02T09:59:12-07:00新型融合模型结合缺氧和免疫特征预测TACE治疗HCC患者的生存 https://news.medxy.ai/ja/new-fusion-model-tace-outcomes/Medxy AIja2026-04-02T09:57:12-07:00新しい融合モデル：低酸素症と免疫特徴を組み合わせてTACE治療中の肝細胞がん患者の予後を予測 https://news.medxy.ai/vi/new-model-oxygens-signs-hcc-survival/Medxy AIvi2026-04-02T09:55:18-07:00Mô hình kết hợp mới kết hợp các dấu hiệu thiếu oxy và miễn dịch để dự đoán sự sống còn của bệnh nhân HCC điều trị bằng phương pháp TACE https://news.medxy.ai/novel-fusion-model-hcc-survival/Medxy AIen2026-04-02T09:51:50-07:00Novel Fusion Model Combines Hypoxia and Immune Signatures to Predict Survival in HCC Patients Undergoing TACE Therapy https://news.medxy.ai/zh/beyond-pathology-dna-rna-sequencing%e8%83%86%e7%ae%a1%e7%99%8c-2/Medxy AIzh2026-04-02T09:43:41-07:00超越病理学：DNA/RNA测序在检测胆管癌中的灵敏度接近翻倍 https://news.medxy.ai/ja/beyond-pathology-dna-rna-sequencing%e8%83%86%e7%ae%a1%e7%99%8c/Medxy AIja2026-04-02T09:42:30-07:00病理学を超えて：DNA/RNAシークエンシングは胆管がんの検出感度をほぼ倍増 https://news.medxy.ai/vi/outside-disease-dna-rna-analysis/Medxy AIvi2026-04-02T09:40:43-07:00Ngoài Bệnh Lý: Phân Tích DNA/RNA Đạt Hiệu Suất Phát Hiện Kém Gấp Đôi Ung Thư Ống Thận https://news.medxy.ai/bile-duct-cancer-sensitivity/Medxy AIen2026-04-02T09:37:50-07:00Beyond Pathology: DNA/RNA Sequencing Achieves Near-Double Sensitivity in Detecting Bile Duct Cancer https://news.medxy.ai/zh/decoding-dementia-variants/Medxy AIzh2026-04-02T08:22:29-07:00解码路易体痴呆：定量病理学、APOE基因型与疾病异质性的相互作用 https://news.medxy.ai/ja/dementia-research-lewy-bodies/Medxy AIja2026-04-02T08:20:39-07:00レビー小体型認知症における認知症の解明：定量病理学、APOE 基因型、および疾患の異質性の相互作用 https://news.medxy.ai/vi/decoding-lewy-body-dementia/Medxy AIvi2026-04-02T08:18:40-07:00Giải mã bệnh mất trí nhớ trong bệnh thể Lewy: Sự tương tác của bệnh lý định lượng, kiểu gen APOE và sự đa dạng của bệnh https://news.medxy.ai/decoding-dementia-lewy-body/Medxy AIen2026-04-02T08:12:32-07:00Decoding Dementia in Lewy Body Disease: The Interplay of Quantitative Pathology, APOE Genotype, and Disease Heterogeneity https://news.medxy.ai/zh/eptinezumab-patient-education-2/Medxy AIzh2026-04-01T19:42:58-07:00Eptinezumab 联合患者教育治疗慢性偏头痛和药物过度使用性头痛：RESOLUTION 试验的见解 https://news.medxy.ai/ja/epcn-education-migraine/Medxy AIja2026-04-01T19:41:07-07:00慢性片頭痛と過剰投薬性頭痛のためのエプチネズマブと患者教育：RESOLUTION試験からの洞察 https://news.medxy.ai/vi/eptinezumab-patient-education/Medxy AIvi2026-04-01T19:37:59-07:00Eptinezumab kết hợp với giáo dục bệnh nhân trong điều trị đau nửa đầu mãn tính và đau đầu do lạm dụng thuốc: Những hiểu biết từ thử nghiệm RESOLUTION https://news.medxy.ai/eptinezumab-chronic-migraine/Medxy AIen2026-04-01T19:34:06-07:00Eptinezumab Combined with Patient Education for Chronic Migraine and Medication-Overuse Headache: Insights from the RESOLUTION Trial https://news.medxy.ai/zh/alzheimer-syndrome-pathology/Medxy AIzh2026-04-01T17:36:03-07:00医源性阿尔茨海默病病理可镜像严重散发性疾病：尸体生长激素暴露后的表现 https://news.medxy.ai/ja/exposure-to-growth-hormone-similarities-alzheimers/Medxy AIja2026-04-01T17:33:08-07:00死体由来の成長ホルモン曝露後の医原性アルツハイマー病変が偶発性アルツハイマー病に類似 https://news.medxy.ai/vi/iatrogenic-alzheimer-disease/Medxy AIvi2026-04-01T17:29:41-07:00Bệnh Alzheimer iatrogene có thể phản ánh bệnh Alzheimer ngẫu nhiên nặng sau khi tiếp xúc với hormon tăng trưởng từ tử thi https://news.medxy.ai/iatrogenic-alzheimer-pathology/Medxy AIen2026-04-01T17:26:07-07:00Iatrogenic Alzheimer Pathology Can Mirror Severe Sporadic Disease After Cadaveric Growth Hormone Exposure https://news.medxy.ai/patient-derived-thyroid-cancer-models/Medxy AIen2026-04-01T15:43:32-07:00Patient-Derived Medullary Thyroid Cancer Models Capture Tumor Plasticity and Drug Resistance Beyond Genomics